NeuroOne Medical Technologies Corp expected to post a loss of 5 cents a share - Earnings Preview
NeuroOne Medical Technologies Corp
NMTC is expected to show a rise in quarterly revenue when it reports results on August 14 for the period ending June 30 2025The Eden Prairie Minnesota-based company is expected to report a 120.4% increase in revenue to $1.82 million from $825.78 thousand a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for NeuroOne Medical Technologies Corp is for a loss of 5 cents per share.
The one available analyst rating on the shares is "strong buy".
The average consensus recommendation for the advanced medical equipment & technology peer group is also "Strong Buy".
Wall Street's median 12-month price target for NeuroOne Medical Technologies Corp is $1.45, about 49.1% above its last closing price of $0.74
